About RiboNova

About company

RiboNova is a biomedical research company in the Lankenau Institute for Medical Research. The company develops a small molecule drugs against a new family of targets, defective transfer RNAs. Its focus is on novel therapies for the treatment of serious rare diseases, including mitochondrial disease and certain cancers.